Subcutaneous (SC) Abatacept (ABA) Versus Intravenous (IV) ABA in Patients (pts) with Rheumatoid Arthritis: Long-Term Data From the ACQUIRE (Abatacept Comparison of Sub[QU]cutaneous versus Intravenous in Inadequate Responders to MethotrexatE) Trial. 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP) Genovese, M. C., Covarrubias Cobos, A., Leon, G., Mysler, E. F., Keiserman, M. W., Valente, R. M., Nash, P. T., Simon Campos, J. A., Porawska, W., Box, J. H., Legerton, C. W., Nasonov, E. L., Durez, P., Pappu, R., Delaet, I., Teng, J., Alten, R. WILEY-BLACKWELL. 2011: S150–S150

View details for Web of Science ID 000297621500402